UPDATE : Tuesday, March 19, 2019
Anticancer drug Riavax used more in last-stage cancer patients by So Jae-hyeon 2018-09-13 15:25
Pharma outlook gloomy amid tax probes, reduced biz days by So Jae-hyeon 2018-09-13 14:39
‘Regulator’s scrutiny into ToolGen’s patent issue might discourage biotech research’ by So Jae-hyeon 2018-09-12 14:25
MERS infection affects stock market by So Jae-hyeon 2018-09-10 16:25
‘Sky Labs’ wearable heart rhythm tracker effective’ by So Jae-hyeon 2018-09-05 16:12
Pfizer seeks Yuhan’s help to keep anti-smoking drug rolling by So Jae-hyeon 2018-09-05 11:59
Pharmaceuticals seek niche with drug reformulation by So Jae-hyeon 2018-09-03 16:49
Will ‘world’s first’ dog dementia treatment work? by So Jae-hyeon 2018-09-03 15:44
Biotech’s big license-out deals calm concerns about bubble by So Jae-hyeon 2018-09-03 14:21
‘₩5 trillion Thai market attractive to Korean drugmakers by So Jae-hyeon 2018-08-31 16:27
Global ban on promotional aids adds burden on local drugmakers by So Jae-hyeon 2018-08-31 14:35
Pharmaceuticals criticize tougher disclosure rules by So Jae-hyeon 2018-08-29 12:02
Viagra impotent in competition against generics by So Jae-hyeon 2018-08-28 16:05
Korea’s Botox export to China plummet amid crackdown on smuggling by So Jae-hyeon 2018-08-17 16:27
Biotech firms grudge over regulator’s plan to toughen disclosure rules by So Jae-hyeon 2018-08-17 11:51
Will Tego Science win reimbursement for diabetic foot ulcer treatment? by So Jae-hyeon 2018-08-16 11:34
Parkinson’s drug Azilect beats market leader Stalevo by So Jae-hyeon 2018-08-13 15:32
[News Focus] Valsartan chaos reveals Korean drugmakers’ weakness by So Jae-hyeon 2018-08-13 14:21
Competition heats up among Korean Botox makers to develop ‘kDa’ by So Jae-hyeon 2018-08-08 16:53
Over 36.8 billion won worth of banned valsartan-based drugs sold last year by So Jae-hyeon 2018-08-07 15:40
Back to Top